scholarly journals Risks and benefits of transnational exchange of forensic DNA data in the EU: The views of professionals operating the Prüm system

2019 ◽  
Vol 68 ◽  
pp. 101872 ◽  
Author(s):  
Helena Machado ◽  
Rafaela Granja
Keyword(s):  
Forensic Dna ◽  
Risks And Benefits ◽  
Transnational Exchange ◽  
The Eu

It’s (just) Chemistry, Stupid! Or Not?

2015 ◽  
Vol 6 (3) ◽  
pp. 423-425
Author(s):  
Justo Corti Varela
Keyword(s):  
Decision Making ◽  
Value Chain ◽  
Institutional Dynamics ◽  
Eu Legislation ◽  
Risks And Benefits ◽  
Modern Biotechnology ◽  
National Attitudes ◽  
The Relationship ◽  
Food Value ◽  
The Eu

This section aims to update readers on decisions related to marketing products of modern biotechnology (e.g., GMOs, animal clones) at EU level and on national measures concerning their production. Special attention is devoted to problems of competence between Member States and the EU in regulating biotechnology issues; the institutional dynamics of decision making regarding products derived frommodern biotechnology; the relationship between the EFSA and the EU institutions on green biotech-related issues; the evolution of EU regulatory framework and of national attitudes towards the risks and benefits of biotechnology derived products and their production. This section will also delve into the interaction between the EU legislation and WTO law regarding advances in the application of biotechnology within the agri–food value chain.

Recent Developments in EU Biotech Regulation: A Possible Solution to the Deadlock on Authorizations of GM Crops?

2010 ◽  
Vol 1 (2) ◽  
pp. 151-152
Author(s):  
Vessela Hristova
Keyword(s):  
Value Chain ◽  
Institutional Dynamics ◽  
Eu Legislation ◽  
Risks And Benefits ◽  
Recent Developments ◽  
Modern Biotechnology ◽  
National Attitudes ◽  
The Relationship ◽  
Food Value ◽  
The Eu

This section aims to update readers on decisions related to marketing products of modern biotechnology (e.g., GMOs, animal clones) at EU level and on national measures concerning their production. Special attention is devoted to problems of competence between Member States and the EU in regulating biotechnology issues; the institutional dynamics of decision making regarding products derived from modern biotechnology; the relationship between the EFSA and the EU institutions on green biotech-related issues; the evolution of EU regulatory framework and of national attitudes towards the risks and benefits of biotechnology derived products and their production. This section will also delve into the interaction between the EU legislation and WTO law regarding advances in the application of biotechnology within the agri-food value chain.

Biotechnology

2010 ◽  
Vol 1 (1) ◽  
pp. 63-71
Author(s):  
Justo Corti Varela
Keyword(s):  
Decision Making ◽  
Value Chain ◽  
Institutional Dynamics ◽  
Eu Legislation ◽  
Risks And Benefits ◽  
Modern Biotechnology ◽  
National Attitudes ◽  
The Relationship ◽  
Food Value ◽  
The Eu

This section aims to update readers on decisions related to marketing products of modern biotechnology (e.g., GMOs, animal clones) at EU level and on national measures concerning their production. Special attention is devoted to problems of competence between Member States and the EU in regulating biotechnology issues; the institutional dynamics of decision making regarding products derived from modern biotechnology; the relationship between the EFSA and the EU institutions on green biotech-related issues; the evolution of EU regulatory framework and of national attitudes towards the risks and benefits of biotechnology derived products and their production. This section will also delve into the interaction between the EU legislation and WTO law regarding advances in the application of biotechnology within the agri-food value chain.

Will Chemical Packages be the only Future for Biotechnology? Why the Bayer-Monsanto Merger Could be a Good Opportunity to Put Things in the Right Place

2016 ◽  
Vol 7 (4) ◽  
pp. 782-783
Author(s):  
Justo Corti Varela
Keyword(s):  
Value Chain ◽  
Good Opportunity ◽  
Institutional Dynamics ◽  
Risks And Benefits ◽  
Modern Biotechnology ◽  
National Attitudes ◽  
The Right ◽  
The Relationship ◽  
Food Value ◽  
The Eu

AbstractThis section aims to update readers on decisions related to marketing products of modern biotechnology (e.g., GMOs, animal clones) at EU level and on national measures concerning their production. Special attention is devoted to problems of competence between Member States and the EU in regulating biotechnology issues; the institutional dynamics of decision making regarding products derived from modern biotechnology; the relationship between the EFSA and the EU institutions on green biotech-related issues; the evolution of EU regulatory framework and of national attitudes towards the risks and benefits of biotechnology derived products and their production. This section will also delve into the interaction between the EU legislation and WTO law regarding advances in the application of biotechnology within the agri-food value chain.

scholarly journals Constructing Suspicion Through Forensic DNA Databases in the EU. The Views of the Prüm Professionals

2019 ◽  
Vol 60 (1) ◽  
pp. 141-159 ◽  
Author(s):  
Helena Machado ◽  
Rafaela Granja ◽  
Nina Amelung
Keyword(s):  
Data Exchange ◽  
Identification System ◽  
The European Union ◽  
Transnational Governance ◽  
Forensic Dna ◽  
Judicial Cooperation ◽  
Dna Databases ◽  
Eu Member States ◽  
Cross Border ◽  
The Eu

Abstract This article explores the fluid and flexible forms of constructing suspicion, which take shape in transnational governance of crime through forensic DNA databases. The empirical examples are the views of professionals engaged with the so-called Prüm system. This technological identification system was developed to enable DNA data exchange across EU Member States in the context of police and judicial cooperation to control cross-border crime and terrorism. We argue that suspicion is constructed through forms of deterritorializing and reterritorializing assumptions about criminality linked to the movements of suspect communities across the European Union. Transnational crime management is configured through narratives of global expansion of criminal mobility, technical neutrality of DNA identification and the reliance on criminal categorizations of particular national populations.

Sign in / Sign up

Export Citation Format

Share Document